ACHV Achieve Life Sciences

Achieve Life Sciences Inc is a specialty pharmaceutical company. The company is developing cytisine as a smoking cessation aid. The cytisine is a plant-based alkaloid with a high binding affinity to the nicotinic acetylcholine receptor.

$8.29
As of 06/24/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/12/1995
Outstanding shares:  6,164,360
Average volume:  276,362
Market cap:   $48,883,375
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    004468500
ISIN:        US0044685008
Sedol:      BLD0Z08
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   8.35
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy